Veloxis Pharmaceuticals

Scroll
Investment area
Principal Investments
Region
Europe
Date of investment
September 2003
Website
http://www.veloxis.com/

Veloxis Pharmaceuticals is a specialty pharmaceutical company focused on the commercialisation of Envarsus XR (extended release Tacrolimus), an immunosuppressant for kidney rejection treatment.